Aptose Bioscns (APTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Operating Expenses | 24,348 | 11,359 | 13,488 | 16,252 | 14,759 |
Operating Income | -24,348 | -11,359 | -13,488 | -16,252 | -14,759 |
Other Income | 24 | 26 | 18 | 25 | 46 |
Pre-tax Income | -24,324 | -11,333 | -13,470 | -16,227 | -14,713 |
Net Income Continuous | -24,324 | -11,333 | -13,470 | -16,227 | -14,713 |
Net Income | $-24,324 | $-11,333 | $-13,470 | $-16,227 | $-14,713 |
EPS Basic Total Ops | -4.05 | -1.95 | -2.25 | -2.70 | -2.40 |
EPS Basic Continuous Ops | -4.08 | -1.91 | -2.27 | -2.74 | -2.44 |
EPS Diluted Total Ops | -4.05 | -1.95 | -2.25 | -2.70 | -2.40 |
EPS Diluted Continuous Ops | -4.08 | -1.91 | -2.27 | -2.74 | -2.44 |
EBITDA(a) | $-24,185 | $-11,204 | $-13,336 | $-16,100 | $-14,605 |